Nihon Nohyaku Receives Approval for Lanoconazole, Antifungal Agent for Athlete's Foot.Tokyo, Japan, Apr 26, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Nihon Nohyaku has received approval for lanoconazole, its proprietary antifungal agent for treating athlete's foot athlete's foot: see ringworm. athlete's foot Form of ringworm that affects the feet. In the inflammatory type, the infection may lie inactive much of the time, with occasional acute episodes in which blisters develop, mostly between the toes. and jockey itch, from the Ministry of Health, Labor and Welfare. The new agent, which is based on the imidazole imidazole /im·id·az·ole/ (im?id-az´ol) 1. a heterocyclic organic compound in which two of five ring atoms are nitrogen; used as an insecticide. 2. any of a class of antifungal compounds containing this structure. compound, has a broad spectrum and strong antifungal activity. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion